JPRN-UMIN000013858
Completed
Phase 2
phase II trial of concurrent chemoradiotherapy (CCRT) with docetaxel + cisplatin + cetuximab for locally advanced squamous cell carcinoma of the head and neck - Phase II trial of CCRT with TP + cetuximab regimen
Department of Biology and Function in the Head and Neck, Yokohama City University Graduate School of Medicine0 sites30 target enrollmentMay 1, 2014
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- advanced squamous cell carcinoma of the head and neck
- Sponsor
- Department of Biology and Function in the Head and Neck, Yokohama City University Graduate School of Medicine
- Enrollment
- 30
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) with distant metastasis 2\) nasopharyngeal cancer 3\) post\-operative chemoradiotherapy 4\) with treatment history of cetuximab or with allergy to taxan, platinum analogue, or cetuximab or with a history of allergy 5\) creatinin clearance \< 65ml/min 6\) with heart disease which is difficult to control 7\) with interstitial pneumonitis or pulmonary fibrosis 8\) with diabetic, hypertension, or liver dysfunction which is difficult to control 9\) with infection which need to treat 10\) with severe drug allergy 11\) pregnant, women who like be pregnant, or man who doesn't agree to contraception during the treatment 12\) doctor's decision not to be registered to this study
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
Phase II study of Concurrent Chemoradiotherapy using Nedaplatin for Locally Advanced Uterine Cervical Carcinoma: Kitasato Gynecologic Radiation Oncology Group 0501 (KGROG0501)ocally Advanced Uterine Cervical CarcinomaJPRN-UMIN000025688Kitasato Gynecologic Radiatoin Oncology Group (KGROG)45
Recruiting
N/A
Clinical trial of concurrent chemoradiotherapy (CCRT) with S-1 in patients with advanced head and neck squamous cell carcinoma, who is not eligible for CCRT with Docetaxel, Cisplatin and 5-Fluorouracil (TPF) regimeadvanced head and neck squamous cell carcinomaJPRN-UMIN000021870Yokohama City University hospital40
Completed
Phase 2
A phase II trial of concurrent chemoradiotherapy with 5-FU plus cisplatin for resectable squamous cell carcinoma of cervical esophaguscervical esophageal cancerJPRN-UMIN000001439ational Cancer Center Hospital32
Withdrawn
N/A
A Phase II Study of concurrent chemo-radiotherapy with Gemcitabine followed by chemotherapy with Gemcitabine and Cisplatin for unresectable localized perihilar cholangiocarcinomaNeoplasmsKCT0003478CC Hospital27
Completed
Phase 2
A phase II study of concurrent chemoradiotherapy with 5-fluorouracil and mitomycin-C for squamous cell carcinoma of the anal canalsquamous cell carcinoma of the anal canalJPRN-UMIN000012184Japanese Radiation Oncology Study Group40